Prevalence of Symptoms ≤1 Year After Acute Illness, by COVID-19 Testing Status Among Adults — Innovative Support for Patients with SARS-CoV-2 Infections Registry, United States, December 2020–March 2023 [3 Supplementary Figures]

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Supplementary Figure 1. Inclusion and Exclusion of Participants, Based on SARS-CoV-2 Test Results at Enrollment — INSPIRE Study, United States, December 2020–March 2023
  
  Supplementary Figure 2. Self-Reported Symptom Prevalence at Baseline and Persistence 3 Through 12 Months Among Adults With Acute COVID-Like Symptoms by COVID-19 Test Status — INSPIRE Study, United States, December 2020–March 2023
  
  Supplementary Figure 3. Self-Reported Prevalence of Emerging and Reemerging Symptoms After Enrollment by Symptom Category Over the Course of 12 Months Among Adults With Acute COVID-19191919–Like Illness, by SARS-CoV-2 Test Status — INSPIRE Study, Uni
  
  
• Subjects:
  COVID-19 Testing
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2023; v. 72, no. 32
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  5 pdf pages
• Volume:
  72
• Issue:
  32
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:8665ef1eea9cb9b3b2ab0d9164934ea6a11e8d29b7382f8fd1328bb9865eb4d94e1fb0eff0239a318e9cd7381bb69583eec9bba8d558b8af57623069f45f8370
• Download URL:
  https://stacks.cdc.gov/view/cdc/131538/cdc_131538_DS1.pdf
• File Type:
  [PDF - 1.06 MB ]